ADC Therapeutics SA
ADCT
$3.70
-$0.26-6.57%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 261.34M | 234.74M | 264.56M | 194.70M | 250.87M |
| Total Receivables | 29.12M | 22.92M | 26.18M | 31.76M | 20.32M |
| Inventory | 4.18M | 18.04M | 17.76M | 17.45M | 2.25M |
| Prepaid Expenses | 5.61M | 5.93M | 4.58M | 6.90M | 8.37M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.08M | 5.52M | 5.66M | 7.18M | 9.45M |
| Total Current Assets | 306.34M | 287.15M | 318.76M | 257.99M | 291.25M |
|
|
|||||
| Total Current Assets | 306.34M | 287.15M | 318.76M | 257.99M | 291.25M |
| Net Property, Plant & Equipment | 1.30M | 1.39M | 1.49M | 13.39M | 13.43M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.52M | 1.22M | 1.32M | 1.16M | 17.30M |
| Total Assets | 323.15M | 289.76M | 321.56M | 272.54M | 321.98M |
|
|
|||||
| Total Accounts Payable | 9.18M | 8.12M | 9.62M | 15.59M | 18.03M |
| Total Accrued Expenses | 43.34M | 43.25M | 42.67M | 31.42M | 49.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.54M | 933.00K | 1.79M | 1.37M | 1.37M |
| Total Finance Division Other Current Liabilities | 14.11M | 9.74M | 10.52M | 9.41M | 11.25M |
| Total Other Current Liabilities | 14.11M | 9.74M | 10.52M | 9.41M | 11.25M |
| Total Current Liabilities | 70.16M | 62.04M | 64.60M | 57.79M | 80.47M |
|
|
|||||
| Total Current Liabilities | 70.16M | 62.04M | 64.60M | 57.79M | 80.47M |
| Long-Term Debt | 434.98M | 455.38M | 447.72M | 440.62M | 433.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.03M | 1.13M | 1.26M | 7.91M | 8.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.81M | 9.39M | 7.17M | 4.45M | 2.43M |
| Total Liabilities | 508.98M | 527.94M | 520.75M | 510.76M | 524.62M |
|
|
|||||
| Common Stock & APIC | 1.45B | 1.39B | 1.39B | 1.29B | 1.29B |
| Retained Earnings | -1.64B | -1.63B | -1.59B | -1.53B | -1.49B |
| Treasury Stock & Other | -722.00K | -907.00K | -595.00K | -1.30M | -1.64M |
| Total Common Equity | -185.83M | -238.18M | -199.18M | -238.22M | -202.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -185.83M | -238.18M | -199.18M | -238.22M | -202.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -185.83M | -238.18M | -199.18M | -238.22M | -202.64M |
|
|
|||||